COMPARISON OF BLEEDING AND TREATMENT PERSISTENCE AMONG NEW USERS OF NOVEL ORAL ANTICOAGULANTS AND WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

被引：3
|
作者：
Lamberts, Morten
Harboe, Louise
Lefevre, Cinira
Evans, David
Gislason, Gunnar
机构：
[1] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark
[2] Bristol Meyers Squibb, Copenhagen, Denmark
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30888-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1268-354
引用
收藏
页码：887 / 887
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF TREATMENT PERSISTENCE IN THE REAL-WORLD USE OF NOVEL ORAL ANTICOAGULANTS AMONG PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Lefevre, Cinira
    Johnson, Michelle
    Collings, Shuk-Li
    Evans, David
    Kloss, Sebastian
    Ridha, Essra
    Maguire, Andrew
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 792 - 792
  • [2] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    [J]. JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [3] Novel oral anticoagulants in non-valvular atrial fibrillation
    Potpara, Tatjana S.
    Lip, Gregory Y. H.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 115 - 129
  • [4] New oral anticoagulants in non-valvular atrial fibrillation
    Francia P.
    Adduci C.
    Santini D.
    Musumeci B.
    Tocci G.
    [J]. High Blood Pressure & Cardiovascular Prevention, 2013, 20 (2) : 53 - 60
  • [5] CHANGES OVER TIME IN TREATMENT PERSISTENCE OF ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Lefevre, Cinira
    Johnson, Michelle
    Collings, Shuk-Li
    Evans, David
    Kloss, Sebastian
    Ridha, Essra
    Maguire, Andrew
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 769 - 769
  • [6] Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation
    Balci, Kevser Gulcihan
    Balci, Mustafa Mucahit
    Canpolat, Ugur
    Sen, Fatih
    Akboga, Mehmet K.
    Suleymanoglu, Muhammed
    Kuyumcu, Serdar
    Maden, Orhan
    Selcuk, Hatice
    Selcuk, Mehmet Timur
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (07): : 474 - 481
  • [7] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [8] Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin
    Francis, Kevin M.
    Siu, Kimberly
    Yu, Chen
    Alvrtsyan, Hasmik
    Rao, Yajing
    Walker, David R.
    Sander, Stephen D.
    Zalesak, Martin
    Miyasato, Gavin
    Sanchez, Herman
    [J]. BLOOD, 2012, 120 (21)
  • [9] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    [J]. NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [10] Changing trends in the use of novel oral anticoagulants and warfarin for treating non-valvular atrial fibrillation
    Birkinshaw, Alexander
    Fry, Christopher H.
    Fluck, David
    Sharma, Pankaj
    Han, Thang S.
    [J]. JRSM CARDIOVASCULAR DISEASE, 2020, 9
12345